ClinicalTrials.gg

Program

PG4

Its studies are mostly in Pneumococcal Infections, led by Pfizer.

Furthest: phase 3, since Apr 30, 20265 company-led studies, 4 open or runningNext primary completion: Mar 4, 2027 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Pfizer54 open or runningphase 3since Apr 30, 2026Jul 23, 2024Mar 4, 2027phase 2 · NCT06524414

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jul 23, 2024First studies: 2 phase 2 studies in Pneumococcal InfectionsFirst studyNCT06531538, NCT06524414
  2. Apr 30, 2026Phase 3 study in Pneumococcal InfectionsPhase 3 reachedNCT07573462 · 2,400 planned · United States, Argentina, Australia and more
  3. May 27, 2026Phase 3 study in Pneumococcal InfectionsNCT07629440 · 3,230 planned · United States, Japan, Puerto Rico
  4. Jun 15, 2026Phase 3 study in Pneumococcal InfectionsNCT07660198 · 1,200 planned · United States, Finland, Poland and more

Ahead

  1. Mar 4, 2027Primary completion: phase 2 study in Pneumococcal InfectionsNCT06524414
  2. Dec 2, 2027Primary completion: phase 3 study in Pneumococcal InfectionsNCT07660198
  3. Dec 30, 2028Primary completion: phase 3 study in Pneumococcal InfectionsNCT07573462
  4. Jun 5, 2029Primary completion: phase 3 study in Pneumococcal InfectionsNCT07629440

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 5 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07660198Pneumococcal Infections · United States, Finland, Poland and more3RecruitingDec 2, 20271,200
NCT07629440Pneumococcal Infections · United States, Japan, Puerto Rico3RecruitingJun 5, 20293,230
NCT07573462Pneumococcal Infections · United States, Argentina, Australia and more3RecruitingDec 30, 20282,400
NCT06531538Pneumococcal Infections · United States, Puerto Rico2CompletedFeb 9, 2026225
NCT06524414Pneumococcal Infections · United States, Puerto Rico2Active, not recruitingMar 4, 2027605

How it is read

Names in the registry

  • “PG4”, 5 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 14, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.